The impact of hospital and surgeon volume on the 30-day mortality of lung cancer surgery: A nation-based reappraisal Pierre-Emmanuel Falcoz, MD, PhD,

Slides:

Advertisements

Similar presentations

The “occasional open heart surgeon” revisited

Advertisements

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis Arman Kilic, MD, Ashish S.

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Characterization and Prediction of Prolonged Air Leak After Pulmonary Resection: A Nationwide Study Setting Up the Index of Prolonged Air Leak Caroline.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Lung cancer screening: No more excuses

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Ground glass opacity of the lung: The veil that needs lifting

Accounting for outcomes: Lies, damned lies, and statistics

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

C. Cameron McCoy, MD, Thomas A. D'Amico, MD

The first Blalock–Taussig shunt

The lord of the rings Antonio Miceli, MD, PhD

Predictors of 90-day mortality after congenital heart surgery: The first report of risk models from a Japanese database Hiroaki Miyata, PhD, Arata Murakami,

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality.

Predictors of survival in lung torsion: A systematic review and pooled analysis Jie Dai, PhD, Dong Xie, MD, Haifeng Wang, MD, Wenxin He, MD, Yiming Zhou,

Yang Zhang, MD, Haiquan Chen, MD, PhD

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

Experience from an American Association for Thoracic Surgery Foundation for Thoracic Surgery Training Fellowship: Lung transplantation in Toronto General.

Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality Christopher M. Pezzi, MD, Katherine Mallin, PhD, Andres Samayoa.

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Get it right the first time

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Left atrial pressure measurement in a rat is currently impossible due to size limitations of balloon occlusion catheter Filip Konecny, MSc, DVM, PhD

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

A fate worse than death Jennifer S. Lawton, MD

Attachment disorder in thoracoabdominal surgery

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Who is your plastic surgeon

Innovation in cardiothoracic surgical training

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Hope should not spring eternal

The continuing challenge of congenital heart disease in China

Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study Pierre-Benoit Pagès, MD, PhD, Jean-Philippe.

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Why arch curvature affects arch resistance

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Preoperative PFTs: The answer is blowing in the wind

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

A good chimney requires a good sweep

Journal changes and initiatives

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Deciding how much to pay for effective care

Presentation transcript:

The impact of hospital and surgeon volume on the 30-day mortality of lung cancer surgery: A nation-based reappraisal Pierre-Emmanuel Falcoz, MD, PhD, Marc Puyraveau, MSc, Caroline Rivera, MD, Alain Bernard, MD, PhD, Gilbert Massard, MD, PhD, Frederic Mauny, MD, PhD, Marcel Dahan, MD, PhD, Pascal-Alexandre Thomas, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 3, Pages 841-848 (September 2014) DOI: 10.1016/j.jtcvs.2014.01.030 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Time trends in observed 30-day mortality: public and private hospitals. Over time, we note a decrease in 30-day mortality both in public and private hospitals with a more significant improvement in the private sector. IC95%, 95% confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 841-848DOI: (10.1016/j.jtcvs.2014.01.030) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Variations in odd ratios (OR) on 30-day mortality by surgeon or hospital volume. The blue curve symbolizes the modelized odds variation by hospital volume for 30-day mortality within the Epithor database. The red curve symbolizes the odds variation by surgeon volume for 30-day mortality within the Epithor database. The reference value is 46 procedures per year by surgeon (OR = 1) corresponding to the mean number of procedures done by a given surgeon within Epithor. The lowest OR is estimated for 89 procedures by year (OR = 0.722), whereas the highest OR is estimated for 30 major procedures per year (OR = 1.081). The Journal of Thoracic and Cardiovascular Surgery 2014 148, 841-848DOI: (10.1016/j.jtcvs.2014.01.030) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions